Latest current cash for BRSF: $750K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current cash for BRSF is $750K as of December 2022. That compares with $790K in the prior-year period — down 4.8% year over year. Investors often review this figure alongside Brain Scientific's historical trend and sector peers before judging valuation or financial health.
Over the past year, BRSF's current cash moved from $790K to $750K — a 4.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Brain Scientific's operating scale or balance-sheet position.
A current cash figure of $750K for BRSF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting BRSF's current cash ($750K), review year-over-year change from $790K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.